JULIE KANE: Open Payments
NPI 1841718590 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 21 payments from 14 companies in 2025. Trend: 2023 $383 · 2024 $445 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Organon LLC | 3 | $80 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Sage Therapeutics, LLC | 2 | $40 |
| CooperSurgical, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: VOQUEZNA, NEXPLANON, ACCRUFER, ZURZUVAE, Paragard T 380A, Veozah, Heplisav-B, Mirena.
Industry payments across VA — which companies pay providers there.
